Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A case of neuronal intranuclear inclusion disease diagnosed 19 years after onset through clinical re-evaluation].

Rinsho shinkeigaku = Clinical neurology·2025
Same author

Immunological and therapeutic insights in autoimmune autonomic ganglionopathy: What is the position of apheresis in immunotherapy?

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2024
Same author

The Presence of Ganglionic Acetylcholine Receptor Antibodies in Sera from Patients with Functional Gastrointestinal Disorders: A Preliminary Study.

Journal of personalized medicine·2024
Same author

[Lambert-Eaton Myasthenic Syndrome].

Brain and nerve = Shinkei kenkyu no shinpo·2024
Same author

Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000).

The Indian journal of medical research·2023
Same author

Immunotherapy for ocular myasthenia gravis: an observational study in Japan.

Therapeutic advances in neurological disorders·2023

Related Experiment Video

Updated: May 16, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

[Plasmapheresis and immunoglobulin therapy].

Hidenori Matsuo1

  • 1National Hospital Organization, Nagasaki Kawatana Medical Center.

Rinsho Shinkeigaku = Clinical Neurology
|December 1, 2012
PubMed
Summary

Plasmapheresis and intravenous immunoglobulin offer short-term relief for myasthenia gravis exacerbations but pose challenges. Optimizing treatment protocols and dosages is crucial for managing this neuromuscular disease effectively.

Area of Science:

  • Neurology
  • Immunology

Context:

  • Myasthenia gravis crisis and acute exacerbations require effective treatments.
  • Plasmapheresis (PP) and intravenous immunoglobulin (IVIG) are established therapeutic options.

Purpose:

  • To address the clinical challenges associated with plasmapheresis and intravenous immunoglobulin in managing myasthenia gravis.
  • To highlight the limitations and adverse effects of current treatments and suggest areas for improvement.

Summary:

  • Both plasmapheresis and IVIG provide temporary symptom improvement, lasting only 2-3 weeks, necessitating further immunosuppressive therapy to prevent relapses.
  • Plasmapheresis carries risks such as hypotension, shock, thromboembolism, and infections, while IVIG has fewer adverse effects but is more costly.
  • Further research is needed to determine optimal plasmapheresis protocols and IVIG dosages for effective myasthenic crisis management.

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

Related Experiment Videos

Last Updated: May 16, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

Impact:

  • This analysis underscores the need for refined treatment strategies to enhance the long-term efficacy and safety of managing myasthenia gravis exacerbations.
  • Identifying optimal treatment parameters can lead to improved patient outcomes and potentially reduce healthcare costs associated with managing myasthenia gravis.